Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ike Dela Peña

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
Medical Hypotheses|July 4, 2016
Chemogenetic approach to model hypofrontalityIke Dela Peña, Wei-Xing Shi
Brain Circulation|October 3, 2018
Granulocyte-colony stimulating factor and umbilical cord blood cell transplantation: Synergistic therapies for the treatment of traumatic brain injuryMichael G Liska, Ike Dela Peña
Translational Stroke Research|October 21, 2015
Translating G-CSF as an Adjunct Therapy to Stem Cell Transplantation for StrokeIke dela Peña, Cesar V Borlongan
Journal of Biomedicine & Biotechnology|September 24, 2011
On benzofuroindole analogues as smooth muscle relaxantsIke dela Peña, Jae Hoon Cheong
Brain Circulation|November 20, 2018
Combination therapy for ischemic stroke: Novel approaches to lengthen therapeutic window of tissue plasminogen activatorTalia Knecht, Cesar Borlongan, Ike Dela Peña
European Journal of Pharmacology|July 26, 2015
Psychostimulants affect dopamine transmission through both dopamine transporter-dependent and independent mechanismsIke Dela Peña, Ruzanna Gevorkiana, Wei-Xing Shi
European Journal of Pharmacology|December 21, 2020
Droxidopa alters dopamine neuron and prefrontal cortex activity and improves attention-deficit/hyperactivity disorder-like behaviors in ratsIke Dela Peña, Guofang Shen, Wei-Xing Shi
Journal of Stroke|February 9, 2017
Strategies to Extend Thrombolytic Time Window for Ischemic Stroke Treatment: An Unmet Clinical NeedIke Dela Peña, Cesar Borlongan, Guofang Shen, et al.
Neural Plasticity|March 12, 2016
Natural Product-Derived Treatments for Attention-Deficit/Hyperactivity Disorder: Safety, Efficacy, and Therapeutic Potential of Combination TherapyJames Ahn, Hyung Seok Ahn, Jae Hoon Cheong, et al.
Pharmacology|June 8, 2011
4-Chloro-7-trifluoromethyl-10H- benzo[4,5]furo[3,2-b]indole-1-carboxylic acid (TBIC), a putative BK(Ca) channel opener with uterine relaxant activitiesHyung Seok Ahn, Ike dela Peña, Yong Chul Kim, et al.
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
Medical Hypotheses|July 4, 2016
Chemogenetic approach to model hypofrontalityIke Dela Peña, Wei-Xing Shi
Brain Circulation|October 3, 2018
Granulocyte-colony stimulating factor and umbilical cord blood cell transplantation: Synergistic therapies for the treatment of traumatic brain injuryMichael G Liska, Ike Dela Peña
Translational Stroke Research|October 21, 2015
Translating G-CSF as an Adjunct Therapy to Stem Cell Transplantation for StrokeIke dela Peña, Cesar V Borlongan
Journal of Biomedicine & Biotechnology|September 24, 2011
On benzofuroindole analogues as smooth muscle relaxantsIke dela Peña, Jae Hoon Cheong
Brain Circulation|November 20, 2018
Combination therapy for ischemic stroke: Novel approaches to lengthen therapeutic window of tissue plasminogen activatorTalia Knecht, Cesar Borlongan, Ike Dela Peña
European Journal of Pharmacology|July 26, 2015
Psychostimulants affect dopamine transmission through both dopamine transporter-dependent and independent mechanismsIke Dela Peña, Ruzanna Gevorkiana, Wei-Xing Shi
European Journal of Pharmacology|December 21, 2020
Droxidopa alters dopamine neuron and prefrontal cortex activity and improves attention-deficit/hyperactivity disorder-like behaviors in ratsIke Dela Peña, Guofang Shen, Wei-Xing Shi
Journal of Stroke|February 9, 2017
Strategies to Extend Thrombolytic Time Window for Ischemic Stroke Treatment: An Unmet Clinical NeedIke Dela Peña, Cesar Borlongan, Guofang Shen, et al.
Neural Plasticity|March 12, 2016
Natural Product-Derived Treatments for Attention-Deficit/Hyperactivity Disorder: Safety, Efficacy, and Therapeutic Potential of Combination TherapyJames Ahn, Hyung Seok Ahn, Jae Hoon Cheong, et al.
Pharmacology|June 8, 2011
4-Chloro-7-trifluoromethyl-10H- benzo[4,5]furo[3,2-b]indole-1-carboxylic acid (TBIC), a putative BK(Ca) channel opener with uterine relaxant activitiesHyung Seok Ahn, Ike dela Peña, Yong Chul Kim, et al.
Pageof 3